TOP2A and cancer: In terms of pathological mechanism, by binding both DNA and topoisomerase 2 (Top2) to form the ternary Top2-anthracycline-DNA cleavage complex, anthracycline inhibits the proliferation of cancer cells by impairing DNA replication and transcription, as well as inducing cell apoptosis [47].